Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

7,150 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Review If "Cellular Surgeons: The New Era Of Nanomedicine"

    A hallmark of nanomedicine is convergence of the fields of robotics, medicine, biotechnology, and nanotechnology to generate multi-functional devices.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Review Of "Cellular Surgeons: The New Era Of Nanomedicine"

    "Cellular surgeons" and "molecular E.R." are just some of the fascinating concepts that were under discussion at the May 30th World Science Festival’s "Cellular Surgeons: The New Era of Nanomedicine"
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
Podcast

S1 E10: As 2026 Approaches, Here's What To Watch (Podcast)

A lot is happening as we look ahead to 2026 from 340B developments to FDA activity, vaccines and more.
United StatesFood, Drugs, Healthcare, Life Sciences
Polsinelli PC
Polsinelli PC
  • Podcast

    Seeds Of Change: How Biotechnology Is Reshaping Agriculture (Podcast)

    Agricultural biotechnology is advancing rapidly, but navigating the regulatory landscape remains complex. This podcast episode examines how the Coordinated Framework divides oversight among USDA, FDA, and EPA, while exploring how gene editing technologies challenge legacy regulations and how national security concerns are driving calls for risk-based regulatory modernization.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Wiley Rein
    Wiley Rein
  • Article

    States Consider "Right-To-Try" Laws To Expand Treatment Options For Terminally Ill

    Some states are beginning to expand treatment options for patients with debilitating conditions through new preapproval programs.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    Stuart Falber On The Life Sciences Industry

    Stuart Falber On The Life Sciences Industry...
    United StatesFood, Drugs, Healthcare, Life Sciences
    WilmerHale
    WilmerHale
  • Article

    Supreme Court Decides Mutual Pharmaceutical Co. v. Bartlett

    As reported on Drug and Device Law Blog, in a five-to-four decision by Justice Alito, the Supreme Court has decided "Mutual Pharmaceutical Co. v. Bartlett".
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    Supreme Court Decision On Reverse Payments Has Significant Implications For Pharmaceutical Manufacturers

    Reed Smith’s Global Regulatory Enforcement Law Blog recently featured a detailed analysis of the Supreme Court’s decision in FTC v. Actavis, where the court ruled five-to-three that reverse payments, also called pay-for-delay settlements, can violate antitrust laws and are subject to antitrust review under the rule-of-reason.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    The Bio/Pharma Beat - January 2020

    We would like to share with you the Bio/Pharma Beat, our monthly newsletter reporting on the patent law developments you should know in biotech, biologics and pharmaceutical cases, legislation and federal agency actions.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Squire Patton Boggs LLP
    Squire Patton Boggs LLP
  • Podcast

    The Intersection Of Life Sciences & AI (Podcast)

    The life sciences industry has always operated on a behemoth of data points, which require meticulous collection, documentation and assessment. Leaders in the field are constantly striving to improve efficiency...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Lewis Brisbois Bisgaard & Smith LLP
    Lewis Brisbois Bisgaard & Smith LLP
  • Article

    The Ninth Circuit Weighs In On CAFA Removal

    Over on the Drug & Device Law blog, Reed Smith partner Steven Boranian examines the Ninth Circuit Court of Appeals’ decision in Corber v. Xanodyne Pharmaceuticals, Inc.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    The Road To Making Birth Control Pills Over-the-Counter In The U.S. (Axios)

    Health experts say making HRA Pharma's Opill pill available without a prescription will prevent more unwanted pregnancies, and the need for abortions.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Transaction Allows Novasep To Accelerate Strategic Project Plan

    Fox was featured in the Yahoo! Finance article, "Transaction Allows Novasep To Accelerate Strategic Project Plan."
    United StatesFood, Drugs, Healthcare, Life Sciences
    Fox Rothschild LLP
    Fox Rothschild LLP
  • Article

    USDA Announces Intent To Reestablish Biotechnology Advisory Committee

    In the February 27, 2015, Federal Register, USDA announced its intent to reestablish the Advisory Committee on Biotechnology and 21st Century Agriculture ("AC21") for a two-year period.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    USDA Determines Certain Herbicide-Resistant Corn, Soybean Not Subject To GMO Regulations

    USDA made the determination based on evaluation of information submitted by the petitioner, public comments, and other publicly available scientific data.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    USDA Extends Period To Comment On Identifying And Reducing Regulatory Burdens

    USDA extended the public comment period until April 27, 2016.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    USDA Issues Final Rule On Chronic Wasting Disease Herd Certification Program

    In the April 24, 2014 Federal Register, USDA issued its final rule governing trafficking controls and fraud investigations.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    USDA Issues Final Rule On Trafficking Controls And Fraud Investigations For SNAP

    In the April 24, 2014 Federal Register, USDA issued its final rule governing trafficking controls and fraud investigations.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    USDA To Grant Exclusive Licenses For Switchgrass, Smooth Bromegrass Varieties

    USDA announced it intends to grant to the University of Nebraska-Lincoln exclusive licenses to the smooth bromegrass variety named "NEWELL" and the switchgrass variety named "LIBERTY."
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    Using Data Better (Video)

    Murad Hussain talks about how life sciences companies and healthcare providers can work with enforcement investigators to encourage a more sophisticated analysis of data.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Showing 181–200 of 7150 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics